“The cancer survivors’ health division of the IEHS focuses on the environment and exposures that occur after a cancer diagnosis. Today, there are more than 15 million cancer survivors living in the United States. The IEHS will bring basic and population science together to address health concerns and discover solutions specific to men and women living with a cancer history. This division is designed to identify solutions that optimize the health of cancer survivors who are vulnerable to adverse health changes in fertility status and reproductive health, fatigue and quality of life, and early onset of age-related chronic conditions such as cardiovascular disease.”
About Dr. Nichols
Hazel Nichols, PhD, is an assistant professor in the Department of Epidemiology at the University of North Carolina’s Gillings School of Global Public Health. Dr. Nichols’ research is based in large observational studies and data resources, including the National Institute of Environmental Health Sciences (NIEHS) Sister Study, the Cancer Research Network and the UNC Cancer Information Population Health Resource (CIPHR). Dr. Nichols is a member of the Cancer Epidemiology Program at the Lineberger Compressive Cancer Center. She is the lead instructor for the EPID 771 Cancer Epidemiology: Survivorship and Outcomes course. Dr. Nichols’ molecular epidemiology studies incorporate biomarkers of ovarian reserve and oxidative stress to understand the consequences of cancer treatment, behavior and environmental exposures for long-term health. Her current NIH-funded research collaborations focus on clinical pregnancy outcomes among female adolescent and young adult cancer survivors. Within the UNC Cancer Survivorship Cohort, she also has investigated urogenital side effects of endocrine therapy among women with a breast cancer diagnosis, and comorbidity burden and frailty among adolescent and young adult cancer survivors.
About the Division
The Cancer Survivors’ Health Division will use population-based, clinical and laboratory research to investigate behavioral and environmental exposures that inform health outcomes after cancer.